US 9468611
d-Methadone for the treatment of psychiatric symptoms
granted A61KA61K31/137A61K45/06
Quick answer
US patent 9468611 (d-Methadone for the treatment of psychiatric symptoms) held by Relmada Therapeutics, Inc. expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relmada Therapeutics, Inc.
- Grant date
- Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/137, A61K45/06, A61K9/0019, A61P